(ABUS) Arbutus Biopharma Weekly charts technical analysis
(ABUS) Arbutus Biopharma Weekly charts technical analysis Weekly analysis of Arbutus Biopharma | Buy/Sell Arbutus Biopharma
Arbutus Biopharma trades in USA in Health Care sector.
10 day averaged volume of Arbutus Biopharma is 568472
| Date | Closing Price | Open | High | Low | Volume |
| 31 Thu Jul 2025 | 3.28 | 3.25 | 3.42 | 3.24 | 2.57 Mn |
| 25 Fri Jul 2025 | 3.22 | 3.13 | 3.30 | 3.11 | 2.397 Mn |
| 18 Fri Jul 2025 | 3.13 | 3.15 | 3.25 | 3.08 | 3.751 Mn |
| 11 Fri Jul 2025 | 3.17 | 3.22 | 3.36 | 3.10 | 4.305 Mn |
| 03 Thu Jul 2025 | 3.24 | 3.12 | 3.28 | 3.04 | 2.973 Mn |
| 27 Fri Jun 2025 | 3.13 | 3.42 | 3.49 | 3.12 | 7.05 Mn |
| 20 Fri Jun 2025 | 3.43 | 3.55 | 3.57 | 3.37 | 2.149 Mn |
| 13 Fri Jun 2025 | 3.53 | 3.51 | 3.62 | 3.45 | 2.491 Mn |
| 06 Fri Jun 2025 | 3.48 | 3.37 | 3.54 | 3.31 | 2.783 Mn |
| 30 Fri May 2025 | 3.36 | 3.24 | 3.54 | 3.24 | 3.365 Mn |
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.26 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Weekly charts
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Arbutus Biopharma in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Arbutus Biopharma is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 3.26 and Arbutus Biopharma (ABUS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.